Daniel Esteban
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Genetics 8
- Chronic Lymphocytic Leukemia Research 7
-
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 3
- Co-authors
- Jordi Esteve (7 shared papers)Josep‐María Ribera (6 shared papers)Joaquín Martínez‐López (5 shared papers)Daniel Martı́nez (2 shared papers)Ramón García‐Sánz (5 shared papers)Eulàlia Genescà (3 shared papers)Paola Castillo (2 shared papers)Alexandra Valera (2 shared papers)
In The Last Decade
Daniel Esteban
18 papers receiving 186 citations
Peers
Comparison fields: 5 of 33
- Genetics 60
- Hematology 63
- Pathology and Forensic Medicine 64
- Oncology 71
- Public Health, Environmental and Occupational Health 48
Countries citing papers authored by Daniel Esteban
This map shows the geographic impact of Daniel Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Esteban more than expected).
Fields of papers citing papers by Daniel Esteban
This network shows the impact of papers produced by Daniel Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Esteban. The network helps show where Daniel Esteban may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Esteban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 2022 | 38 | |
| 3 | 2024 | 17 | |
| 4 | 2023 | 16 | |
| 5 | 2010 | 14 | |
| 6 | 2024 | 11 | |
| 7 | 2022 | 9 | |
| 8 | 2007 | 8 | |
| 9 | Cancer in the Philippines | 1989 | 5 |
| 10 | 2023 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2009 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2025 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2025 | 0 |
About Daniel Esteban
Daniel Esteban is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 19 papers that have together received 189 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Alzheimer's disease research and treatments (1 paper) and Surgical Simulation and Training (1 paper). The work is most often cited by research in Genetics (60 citations), Hematology (63 citations), Pathology and Forensic Medicine (64 citations), Oncology (71 citations) and Public Health, Environmental and Occupational Health (48 citations). Daniel Esteban has collaborated with scholars based in Spain, Germany and Belgium. Frequent co-authors include Jordi Esteve, Josep‐María Ribera, Joaquín Martínez‐López, Daniel Martı́nez, Ramón García‐Sánz, Eulàlia Genescà, Paola Castillo, Alexandra Valera, Arancha Bermúdez and Armando López‐Guillermo. Their work appears in journals such as Blood, HemaSphere, Journal of Clinical Oncology, Blood Advances and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.